If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point
Under the CMS guidelines, Wegovy can be prescribed only to people with heart disease who are either overweight or obese
Semaglutide supports this transition by improving hormonal balance and encouraging a steady calorie deficit
Error 1: confusing units with the dose A provider tells a patient to "take 5 units." The patient sees the number 5 on their syringe and draws to that line
Although fibrosis improvement remains limited, they manage metabolic liver conditions by reducing inflammation and fat deposition, and combining them with anti-inflammatory therapies may enhance the therapeutic efficacy (Table 1 shows representative clinical trials and results of GLP-1RAs in liver diseases